{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:19:38Z","timestamp":1790943578619,"version":"4.1.0"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2009,4,28]],"date-time":"2009-04-28T00:00:00Z","timestamp":1240876800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0005355","type":"journal-article","created":{"date-parts":[[2009,4,27]],"date-time":"2009-04-27T23:10:05Z","timestamp":1240873805000},"page":"e5355","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":62,"title":["Extraction and Inhibition of Enzymatic Activity of Botulinum Neurotoxins\/A1, \/A2, and \/A3 by a Panel of Monoclonal Anti-BoNT\/A Antibodies"],"prefix":"10.1371","volume":"4","author":[{"given":"Suzanne R.","family":"Kalb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlong","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Consuelo","family":"Garcia-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isin N.","family":"Geren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hercules","family":"Moura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L.","family":"Pirkle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2009,4,28]]},"reference":[{"key":"ref1","article-title":"<italic>Botulism in the United States: Handbook for Epidemiologists, Clinicians and Laboratory Workers<\/italic>","volume":"1998","year":"1899"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1152\/physrev.2000.80.2.717","article-title":"Neurotoxins affecting neuroexocytosis.","volume":"80(2)","author":"G Schiavo","year":"2000","journal-title":"Physiol Rev"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum toxin as a biological weapon: medical and public health management.","volume":"285(8)","author":"SS Arnon","year":"2001","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.febslet.2006.02.074","article-title":"The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves.","volume":"580","author":"S Mahrhold","year":"2006","journal-title":"FEBS Letters"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","article-title":"SV2 is the protein receptor for botulinum neurotoxin A.","volume":"312","author":"M Dong","year":"2006","journal-title":"Science"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.pharmtox.44.101802.121554","article-title":"Identification of the major steps in botulinum toxin action.","volume":"44","author":"LL Simpson","year":"2004","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3201\/eid1110.041279","article-title":"Botulinum neurotoxin detection and differentiation by mass spectrometry.","volume":"11(10)","author":"JR Barr","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1021\/ac050485f","article-title":"From the mouse to the mass spectrometer: detection and differentiation of the endoproteinase activities of botulinum neurotoxins A\u2013G by mass spectrometry.","volume":"7","author":"AE Boyer","year":"2005","journal-title":"Anal Chem"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ab.2006.01.027","article-title":"The Use of Endopep-MS for the detection of botulinum neurotoxins A, B, E, and F in serum and stool samples.","volume":"351(1)","author":"SR Kalb","year":"2006","journal-title":"Anal Biochem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1021\/ac0511748","article-title":"Detection of botulinum neurotoxin A in a spiked milk sample with subtype identification through toxin proteomics.","volume":"77(19)","author":"SR Kalb","year":"2005","journal-title":"Anal Chem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/104063870701900402","article-title":"Detection of Botulinum Type E Toxin in channel catfish with visceral toxicosis syndrome using catfish bioassay and endopep mass spectrometry.","volume":"19(4)","author":"PS Gaunt","year":"2007","journal-title":"J Vet Diagn Invest"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijms.2008.04.004","article-title":"The Use of Endopep-MS to detect multiple subtypes of botulinum neurotoxins A, B, E, and F.","volume":"278","author":"SR Kalb","year":"2008","journal-title":"International Journal of Mass Spectrometry"},{"key":"ref13","first-page":"541","article-title":"Collaborative study of a method for the detection of <italic>Clostridium botulinum<\/italic> and its toxins in foods.","volume":"60(3)","author":"DA Kautter","year":"1977","journal-title":"J Assoc Anal Chem"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1432-1033.1994.tb19926.x","article-title":"Antagonism of the intracellular action of botulinum neurotoxin type A with monoclonal antibodies that map to light-chain epitopes.","volume":"219","author":"I Cenci Di Bello","year":"1994","journal-title":"Eur J Biochem"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nbt1269","article-title":"Molecular evolution of antibody cross-reactivity for two subtypes of type A botulinum neurotoxin.","volume":"25","author":"C Garcia-Rodriguez","year":"2007","journal-title":"Nat Biotechnol"},{"key":"ref16","first-page":"277","article-title":"Recombinant anti-botulinum neurotoxin A single-chain variable fragment antibody generated using a phage display system.","volume":"22(5)","author":"DC Mah","year":"2003","journal-title":"Hybrid Hybridomics"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"11346","DOI":"10.1073\/pnas.172229899","article-title":"Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.","volume":"99(17)","author":"A Nowakowski","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1128\/IAI.69.1.570-574.2001","article-title":"High-affinity, protective antibodies to the binding domain of botulinum neurotoxin type A.","volume":"69","author":"DD Pless","year":"2001","journal-title":"Infect Immun"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jmb.2005.06.003","article-title":"Molecular evolution of antibody affinity for sensitive detection of botulinum neurotoxin type A.","volume":"351","author":"A Razai","year":"2005","journal-title":"J Mol Biol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1128\/AEM.50.1.63-67.1985","article-title":"Monoclonal antibody-based immunoassay for type A <italic>Clostridium botulinum<\/italic> toxin is comparable to the mouse bioassay.","volume":"50","author":"C Shone","year":"1985","journal-title":"Appl Environ Microbiol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1128\/IAI.65.9.3743-3752.1997","article-title":"Molecular characterization of murine humoral immune response to botulinum neurotoxin type A binding domain as assessed by using phage antibody libraries.","volume":"65","author":"P Amersdorfer","year":"1997","journal-title":"Infection Immunity"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/S0264-410X(01)00482-0","article-title":"Genetic and immunological comparison of anti-botulinum type A antibodies from immune and non-immune human phage libraries.","volume":"20","author":"P Amersdorfer","year":"2002","journal-title":"Vaccine"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1128\/JB.01180-06","article-title":"Genetic diversity among Botulinum Neurotoxin-producing clostridial strains.","volume":"189(3)","author":"KK Hill","year":"2007","journal-title":"J Bacteriol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1128\/IAI.73.9.5450-5457.2005","article-title":"Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.","volume":"73(9)","author":"TJ Smith","year":"2005","journal-title":"Infect Immun"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0041-0101(03)00042-4","article-title":"Expression, purification, and efficacy of the type A botulinum neurotoxin catalytic domain fused to two translocation domain variants.","volume":"41(6)","author":"MJ Jensen","year":"2003","journal-title":"Toxicon"},{"key":"ref26","article-title":"Human monoclonal antibodies to botulinum neurotoxin types A and B from immune yeast displayed antibody libraries.","author":"IN Geren"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jmb.2006.09.084","article-title":"Fine and domain-level epitope mapping of botulinum neurotoxin type a neutralizing antibodies by yeast surface display.","volume":"365","author":"R Levy","year":"2007","journal-title":"J Mol Biol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/2338","article-title":"Crystal structure of botulinum neurotoxin type A and implications for toxicity.","volume":"5(10)","author":"DB Lacy","year":"1998","journal-title":"Nat Struct Biol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0005355","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T19:53:11Z","timestamp":1589745191000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0005355"}},"subtitle":[],"editor":[{"given":"Christophe","family":"Herman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,4,28]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2009,4,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0005355","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,28]]}}}